Advancing discoveries to beat cancer and thus maximising patient benefit is at the heart of what we do. We achieve this through:
Sourcing and developing cancer discoveries.
We work closely with research scientists to identify, evaluate and protect new cancer discoveries and inventions – whether it is through the £315m of Cancer Research UK-funded research we have exclusive Intellectual Property rights to, or those sourced from our relationships with funding bodies and research partners worldwide.
Providing best in class technology transfer services to cancer researchers.
Our business managers will propose a development pathway to ensure not only the strongest commercial value is established for each project but that it also has the strongest chance of reaching clinical trial stage. To add value to or further develop a project, we will recommend the right course of action to be undertaken within CRT's Discovery Laboratories, the host institution or through collaboration with a commercial partner or other academic partners in our network.
Realising with industry partners, optimal commercial value to support further research and patient benefit.
Establishing the right commercial exploitation strategy calls for considerable knowledge of oncology research, the immediate development needs of the project, and its potential market value. CRT has built up a global network of commercial tools to successfully transfer inventions to commercial partners.
Identifying innovative scientific and business solutions to unmet needs in cancer.
Groundbreaking innovation is at the core of what we do, and our work is at the forefront of advancing cancer discoveries. We are constantly looking to expand our offerings to meet the unmet needs in cancer therapeutics.
© Cancer Research Technology 2012